Related Experiment Videos
[Replacement therapy in adrenopause. Dehydroepiandrosterone and aging]
1Cattedra di Geriatria, Dipartimento di Terapia Medica, Università La Sapienza, Roma.
Recenti Progressi in Medicina
|March 23, 2001
Summary
Dehydroepiandrosterone (DHEA) replacement therapy may benefit elderly individuals in areas like muscle and bone health. However, more research is needed as its routine use remains controversial.
Area of Science:
- Endocrinology and Aging Research
- Steroid Hormone Biology
Context:
- Dehydroepiandrosterone (DHEA) and its sulfated ester (DHEAS) are abundant adrenal steroids with incompletely understood functions.
- Serum DHEAS levels decline with age, correlating with age-related conditions like immunosenescence, osteoporosis, atherosclerosis, cancer, and cognitive decline.
Purpose:
- To review recent findings on DHEA replacement therapy in the elderly.
- To evaluate the potential benefits and controversies surrounding DHEA supplementation in aging populations.
Summary:
- DHEA replacement therapy has shown some positive effects on muscle mass, bone density, and overall well-being in elderly individuals.
- Despite promising data, conclusive evidence supporting routine DHEA replacement is lacking due to ongoing controversies and the need for further investigation.
Impact:
- Provides a critical overview of DHEA replacement therapy for aging populations.
- Highlights the need for continued research to clarify the role of DHEA in mitigating age-related decline and its therapeutic potential.